$59.07
+0 (+0%)
At Close: Aug 17, 2022
NEW YORK--(BUSINESS WIRE)--The New York Times Company (NYSE: NYT) announced today that it will participate in the J.P. Morgan Global Technology, Media and Communications Conference on Tuesday, May 19,
NEW YORK--(BUSINESS WIRE)--The New York Times Company (NYSE: NYT) announced today that it will participate in the Morgan Stanley Technology, Media & Telecom Conference on Monday, March 2, 2026, in San
Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call Transcript
03:14pm, Thursday, 12'th Feb 2026
Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call Transcript
Medexus Pharmaceuticals (TSE:MDP) Trading Up 2.1% – What’s Next?
03:30am, Tuesday, 27'th Jan 2026
Medexus Pharmaceuticals Inc. (TSE: MDP - Get Free Report)'s stock price traded up 2.1% during mid-day trading on Monday. The company traded as high as C$2.93 and last traded at C$2.93. 68,477 shares w
Medexus Pharmaceuticals (TSE:MDP) Trading Up 0.8% – Time to Buy?
02:41am, Friday, 12'th Dec 2025
Medexus Pharmaceuticals Inc. (TSE: MDP - Get Free Report) shares were up 0.8% during trading on Thursday. The stock traded as high as C$2.66 and last traded at C$2.64. Approximately 67,005 shares trad
Meredith Whitney CEO on why EVs will be a massive play in Europe
12:19pm, Monday, 08'th Dec 2025
Meredith Whitney, founder and CEO of Meredith Whitney Advisory Group, joins CNBC's ‘Money Movers' to discuss key takeaways from her recent trip to the BYD factory in Shenzhen, the automaker's global
NEW YORK--(BUSINESS WIRE)--The New York Times Company (NYSE: NYT) announced today that it will participate in the UBS Global Media and Telecom Conference on Tuesday, December 9, 2025, in New York City
Medexus Pharmaceuticals Inc. (MDP:CA) Q2 2026 Earnings Call Transcript
10:11am, Thursday, 13'th Nov 2025
Medexus Pharmaceuticals Inc. ( MDP:CA ) Q2 2026 Earnings Call November 13, 2025 8:00 AM EST Company Participants Kenneth d'Entremont - CEO & Director Brendon Bushman - Chief Financial Officer Conferen
Medexus Pharmaceuticals Inc. (MDP:CA) Shareholder/Analyst Call Prepared Remarks Transcript
11:27am, Thursday, 25'th Sep 2025
Medexus Pharmaceuticals Inc. (TSX:MDP:CA ) Shareholder/Analyst Call September 25, 2025 10:00 AM EDT Company Participants Michael Mueller Ian Wildgoose Brown - General Counsel & Corporate Secretary Bre
Medexus Pharmaceuticals Inc. (MEDXF) Q1 2026 Earnings Call Transcript
10:19am, Wednesday, 13'th Aug 2025
Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q1 2026 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Brendon Buschman - Chief Financial Officer Kenneth d'Entremont - CEO & Direc
Dotdash Meredith is now People Inc.
10:15am, Thursday, 31'st Jul 2025
NEW YORK , July 31, 2025 /PRNewswire/ -- Dotdash Meredith, the largest digital and print publisher in America, announced it is now People Inc. The new name represents the next chapter for the owner of
Housing market will have 'worst year in decades,' analyst says
01:02pm, Tuesday, 24'th Jun 2025
KB Home (KBH) slashed its full-year revenue outlook after a weak second quarter, highlighting just how sluggish the housing market has become, with existing home sales seeing their worst May since 200
Dotdash Meredith Appoints Jim Lawson as President of D/Cipher
10:22am, Monday, 17'th Mar 2025
Former AdTheorent CEO to lead D/Cipher's evolution as the premier cookie-less ad targeting and buying solution for the open Internet NEW YORK , March 17, 2025 /PRNewswire/ -- Today Dotdash Meredith (
NEW YORK--(BUSINESS WIRE)--The New York Times Company (NYSE: NYT) announced today that it will participate in the Morgan Stanley Technology, Media & Telecom Conference on Monday, March 3, 2025, in San
Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares
08:38am, Friday, 31'st Jan 2025
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 31, 2025) - Medexus Pharmaceuticals Inc. (TSX: MDP) ("Medexus" or the "Company"), is pleased to announce the closing of its previously
Sign In
Buy MDP